Brought to you by:
CLOUT registry: Interim two-year rates of PTS ‘significantly lower’ than those in historical DVT studies
Rates of post-thrombotic syndrome (PTS) among deep vein thrombosis (DVT) patients treated with the ClotTriever thrombectomy system (Inari Medical) who are logged in the real-world CLOUT registry demonstrated “significant and sustained improvement” out to 24 months, according to interim two-year…
AVF 2024: Outgoing president addresses history, future direction of American Venous Forum
At the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), Glenn Jacobowitz, MD, professor of vascular and endovascular surgery at NYU Langone Health in New York City and 2023-24 AVF president, tackled the future direction of the society—and…
Non-pneumatic compression device performed better than advanced pneumatic compression for lower extremity lymphedema
A new study presented during the 2024 American Venous Forum (AVF) in Tampa, Florida (March 3–6), that compared a novel non-pneumatic compression device with an advanced pneumatic compression modality in the treatment of lower extremity lymphedema demonstrated “statistically significant disruption”…
Adoption of AI into workflow associated with faster time to assessment of PE patients
An abstract presented at the 2024 American Venous Forum (AVF) annual meeting (March 3–6) revealed that, in the treatment of patients with pulmonary embolism (PE), the implementation of artificial intelligence (AI) software has been linked to a shorter time to…
SCAI, SIR, SVS jointly publish proceedings from multispecialty peripheral IVUS roundtable
Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ultrasound (IVUS) in lower extremity revascularization procedures were released today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), Journal of Vascular and Interventional Radiology (JVIR), and Journal of…
Corner Stitch: On the vascular trainee opportunities on the conference calendar
Christopher Audu, MD, surveys the 2024 meeting landscape, highlighting prime opportunities for trainees to showcase their research. It is abstract submission, and this month I wanted to highlight a few national meetings that are “trainee friendly” for getting your work…
JVS-VL to be open access beginning in January
The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) will move from a subscription model to one of open access—freely available online—on Jan. 1, 2024. JVS-VL is the journal for both the SVS and the American Venous Forum (AVF)…
JVS-VL peer-review title launches virtual special issue on diversity topics
The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) has launched its first virtual special issue on diversity, equity and inclusion (DEI) in vascular surgery. “DEI issues have come to the forefront and affect multiple aspects of the care…
Bioprosthetic venous valve: ‘We want to know that this is really working’
A key investigator in efforts to tackle chronic venous insufficiency (CVI) with an bioprosthetic venous valve replacement talks about progress being made with surgical and endovascular versions of the device—and surgical community skepticism. Jorge Ulloa, MD, has not long since…
Venous stenting: ‘We need to evaluate use, appropriateness and clinical indication’
An analysis of venous stent usage trends in the United States from 2014 through 2021 showed a “significant increase” in stents per day placed over time, despite high-profile recalls of two dedicated venous stents from the market. Those were among…